InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.80
(
0.41%
)
US TECH 100
19,548.00
(
1.00%
)
Dow Jones
42,052.19
(
0.69%
)
Brent Oil
72.91
(
-1.49%
)
Bitcoin
69,341.72
(
-1.24%
)
Post# of 253509
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: DewDiligence post# 94353

Saturday, 04/17/2010 7:29:40 PM

Saturday, April 17, 2010 7:29:40 PM

Post# of 253509
RE: Roche potential future HCV licensing.

Good point on the IDIX potential licensing... I am sure that would be a big blow to VRUS should that happen.

From InterMune calls and making a huge speculation I wouldn't be shocked if Roche tries adding a third drug with a new mechanism in the not too distant future (I believe they have their own internal Helicase program). It seems now there are a number of QD candidates in the < 200-300mg range so coformulation may be a bit more practical.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up